Members of DVCA
NB CapitalNB CapitalLife Sciences
Kontaktperson: Florian Schönharting
NB Capital was seeded in 2001 by a small group of highly experienced biotech investors and a pharmaceutical company. Since the beginning we have been focused on investing capital in public and private equity markets using principles of risk aversion and innovation.